Insider · CIK 0002053910
Kristen Landon
Files at SXTP (60 DEGREES PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
Kristen Landon files SEC Form 4 as COO at SXTP (60 DEGREES PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kristen Landon has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | AGrant or award Common Stock | +4,540 | $0.00 | $0 | 4,540 | Aug 14, 2025 |
| Sep 26, 2024 | SXTP 60 DEGREES PHARMACEUTICALS, INC. | AGrant or award Stock Options (Right to Buy)derivative | +4,167 | $0.00 | $0 | 4,167 | Aug 14, 2025 |
Questions about Kristen Landon
Answered from the filings on this page, as of the latest one.
Is Kristen Landon buying or selling?
Kristen Landon has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kristen Landon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kristen Landon has 0.
Where does Kristen Landon file Form 4?
Kristen Landon has filed Form 4 at SXTP (60 DEGREES PHARMACEUTICALS, INC.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.